Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 2
1982 5
1983 2
1984 2
1985 3
1986 7
1987 1
1988 2
1989 2
1991 2
1992 6
1993 6
1994 9
1995 13
1996 21
1997 20
1998 17
1999 20
2000 30
2001 26
2002 36
2003 51
2004 51
2005 60
2006 63
2007 77
2008 103
2009 106
2010 123
2011 126
2012 176
2013 224
2014 224
2015 258
2016 264
2017 286
2018 319
2019 402
2020 537
2021 616
2022 706
2023 714
2024 328

Text availability

Article attribute

Article type

Publication date

Search Results

5,395 results

Results by year

Filters applied: . Clear all
Page 1
Brain endothelial GSDMD activation mediates inflammatory BBB breakdown.
Wei C, Jiang W, Wang R, Zhong H, He H, Gao X, Zhong S, Yu F, Guo Q, Zhang L, Schiffelers LDJ, Zhou B, Trepel M, Schmidt FI, Luo M, Shao F. Wei C, et al. Among authors: zhong h. Nature. 2024 Apr 17. doi: 10.1038/s41586-024-07314-2. Online ahead of print. Nature. 2024. PMID: 38632402
Nimotuzumab Plus Gemcitabine for K-Ras Wild-Type Locally Advanced or Metastatic Pancreatic Cancer.
Qin S, Li J, Bai Y, Wang Z, Chen Z, Xu R, Xu J, Zhang H, Chen J, Yuan Y, Liu T, Yang L, Zhong H, Chen D, Shen L, Hao C, Fu D, Cheng Y, Yang J, Wang Q, Qin B, Pan H, Zhang J, Bai X, Zheng Q. Qin S, et al. Among authors: zhong h. J Clin Oncol. 2023 Nov 20;41(33):5163-5173. doi: 10.1200/JCO.22.02630. Epub 2023 Aug 30. J Clin Oncol. 2023. PMID: 37647576 Clinical Trial.
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial.
Gao X, Xu N, Li Z, Shen L, Ji K, Zheng Z, Liu D, Lou H, Bai L, Liu T, Li Y, Li Y, Fan Q, Feng M, Zhong H, Huang Y, Lou G, Wang J, Lin X, Chen Y, An R, Li C, Zhou Q, Huang X, Guo Z, Wang S, Li G, Fei J, Zhu L, Zhu H, Li X, Li F, Liao S, Min Q, Tang L, Shan F, Gong J, Gao Y, Zhou J, Lu Z, Li X, Li J, Ren H, Liu X, Yang H, Li W, Song W, Wang ZM, Li B, Xia M, Wu X, Ji J. Gao X, et al. Among authors: zhong h. Lancet Oncol. 2023 Oct;24(10):1134-1146. doi: 10.1016/S1470-2045(23)00411-4. Lancet Oncol. 2023. PMID: 37797632 Clinical Trial.
APR-246 increases tumor antigenicity independent of p53.
Michels J, Venkatesh D, Liu C, Budhu S, Zhong H, George MM, Thach D, Yao ZK, Ouerfelli O, Liu H, Stockwell BR, Campesato LF, Zamarin D, Zappasodi R, Wolchok JD, Merghoub T. Michels J, et al. Among authors: zhong h. Life Sci Alliance. 2023 Oct 27;7(1):e202301999. doi: 10.26508/lsa.202301999. Print 2024 Jan. Life Sci Alliance. 2023. PMID: 37891002 Free PMC article.
Piezo channels in the intestinal tract.
He H, Zhou J, Xu X, Zhou P, Zhong H, Liu M. He H, et al. Among authors: zhong h. Front Physiol. 2024 Feb 6;15:1356317. doi: 10.3389/fphys.2024.1356317. eCollection 2024. Front Physiol. 2024. PMID: 38379701 Free PMC article. Review.
Non-alcoholic fatty liver disease: pathogenesis and models.
Zhong H, Dong J, Zhu L, Mao J, Dong J, Zhao Y, Zou Y, Guo M, Ding G. Zhong H, et al. Am J Transl Res. 2024 Feb 15;16(2):387-399. doi: 10.62347/KMSA5983. eCollection 2024. Am J Transl Res. 2024. PMID: 38463579 Free PMC article. Review.
Research progress on the pathogenesis of diabetic retinopathy.
Li H, Liu X, Zhong H, Fang J, Li X, Shi R, Yu Q. Li H, et al. Among authors: zhong h. BMC Ophthalmol. 2023 Sep 11;23(1):372. doi: 10.1186/s12886-023-03118-6. BMC Ophthalmol. 2023. PMID: 37697295 Free PMC article. Review.
5,395 results